SNWV
SANUWAVE Health, Inc.NASDAQHealthcare$16.90+0.30%ClosedMarket Cap: $145.2M
As of 2026-04-06
Valuation
P/E (TTM)
12.30
PEG
0.09
P/B
90.50
P/S
3.34
EV/EBITDA
25.38
DCF Value
$-48.85
FCF Yield
2.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.1%
Operating Margin
11.2%
Net Margin
26.8%
ROE
-141.6%
ROA
31.6%
ROIC
19.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $13.1M | 69.1% | $615.0K | $6.1M | $0.02 | — |
| FY 2025 | $44.1M | 75.1% | $4.9M | $11.8M | $0.41 | — |
| Q3 2025 | $11.5M | 76.0% | $1.5M | $10.3M | $1.13 | — |
| Q2 2025 | $10.2M | 78.3% | $1.9M | $1.1M | $0.01 | — |
| Q1 2025 | $9.3M | 79.0% | $986.0K | $-5.7M | $-0.66 | — |
| Q4 2024 | $10.3M | 77.9% | $2.5M | $-12.7M | $-3.33 | — |
| FY 2024 | $32.6M | 75.2% | $5.4M | $-31.4M | $-7.03 | — |
| Q3 2024 | $9.4M | 75.5% | $2.0M | $-20.7M | $-6.49 | — |
| Q2 2024 | $7.2M | 73.2% | $2.0M | $6.6M | $1.77 | — |
| Q1 2024 | $5.8M | 72.6% | $-1.1M | $-4.5M | $-1.46 | — |
| Q4 2023 | $7.0M | 66.4% | $1.0M | $18.2M | $6.00 | — |
| FY 2023 | $20.4M | 70.4% | $-540.0K | $-25.8M | $-12.19 | — |